Insilicos was issued a patent for diagnosis of cardiovascular disease.
This is the first issued patent that I have been an inventor on. It's exciting, since the patent actually matters for our diagnostic work.
The method is for analysis of proteins carried by HDL particles. It's directly related to our ongoing clinical study to predict heart attacks in advance from a blood test.
I'm really excited about the potential for this test to be a breakthrough in diagnosing CVD. You never know for sure until you have the data in hand, but I'm optimistic.